Banaag, Charles John Mark H.
HRN: 10-63-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2023
CEFUROXIME 750MG (VIAL)
04/27/2023
05/04/2023
IVT
700mg
Q8
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes